Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.79%
)
Brent Oil
91.37
(
-1.39%
)
Bitcoin
74,697.24
(
1.13%
)
News Focus
News Focus
Post# of 821985
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

HyGro

Send PM Follow Ignore
Followers 24
Posts 4173
Boards Moderated 0
Alias Born 12/18/2019

HyGro

Re: SkyLimit2022 post# 597601

Friday, 06/02/2023 12:20:35 AM

Friday, June 02, 2023 12:20:35 AM

Post# of 821985
I made a very nice profit. The Optune P3 data was all very positive and the P3 should all be similar. The cost of commercialization is something I don't want to wait around for in biotechs.

Like NWBO -- they have NO resources to get payers signed up, get leading medical associations to endorse, and then get to all the leading treaters. Takes a long time and is expensive. NWBO by no means has the cash, the expertise and manpower to do it. How much ya lost on NWBO?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News